Russia's competition watchdog has approved Pharmacy Chain 36.6's purchase of the Russian business of Finnish drug retail and wholesale chain Oriola-KD.
Timur Shkaya, Pharmacy Chain 36.6's co-owner, told Reuters on Friday the company planned to close the deal on Monday.
The purchase, valued at up to 100 million euros ($123 million), was approved by Russia's Anti-Monopoly Service (FAS), he said.
Oriola-KD took a $100 million impairment charge in June due to weaker growth prospects in Russia.
Russia's economy has been hit by Western sanctions over Moscow's role in the Ukraine conflict.
Oriola-KD generated around 1 billion euros in sales in Russia last year. It owns the 03-Apteka and Stary Lekar drug store chains, as well as distributor Oriola.
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.